The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
Saved in:
| Title: | The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study. |
|---|---|
| Authors: | Schmit N; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK. Electronic address: n.schmit17@imperial.ac.uk., Topazian HM; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Natama HM; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Bellamy D; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Traoré O; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Somé MA; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Rouamba T; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Tahita MC; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Bonko MDA; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Sourabié A; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Sorgho H; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso., Stockdale L; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Provstgaard-Morys S; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Aboagye J; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Woods D; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Rapi K; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Datoo MS; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Lopez FR; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Charles GD; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., McCain K; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Ouedraogo JB; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso; Institut des Sciences et Techniques-Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso., Hamaluba M; Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Olotu A; Clinical Trials and Interventions Unit, Ifakara Health Institute, Bagamoyo, Tanzania., Dicko A; The Malaria Research and Training Centre, University of Science, Technology, and Techniques of Bamako, Bamako, Mali., Tinto H; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso; Institut des Sciences et Techniques-Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso., Hill AVS; The Jenner Institute Laboratories, University of Oxford, Oxford, UK., Ewer KJ; The Jenner Institute Laboratories, University of Oxford, Oxford, UK; GSK Vaccines Institute for Global Health (Global Health Vaccines R&D), GSK, Siena, Italy., Ghani AC; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Winskill P; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2024 May; Vol. 24 (5), pp. 465-475. Date of Electronic Publication: 2024 Feb 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38342107 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schmit+N%22">Schmit N</searchLink>; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK. Electronic address: n.schmit17@imperial.ac.uk.<br /><searchLink fieldCode="AU" term="%22Topazian+HM%22">Topazian HM</searchLink>; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Natama+HM%22">Natama HM</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Bellamy+D%22">Bellamy D</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Traoré+O%22">Traoré O</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Somé+MA%22">Somé MA</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Rouamba+T%22">Rouamba T</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Tahita+MC%22">Tahita MC</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Bonko+MDA%22">Bonko MDA</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Sourabié+A%22">Sourabié A</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Sorgho+H%22">Sorgho H</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Stockdale+L%22">Stockdale L</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Provstgaard-Morys+S%22">Provstgaard-Morys S</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Aboagye+J%22">Aboagye J</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Woods+D%22">Woods D</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Rapi+K%22">Rapi K</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Datoo+MS%22">Datoo MS</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Lopez+FR%22">Lopez FR</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Charles+GD%22">Charles GD</searchLink>; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22McCain+K%22">McCain K</searchLink>; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ouedraogo+JB%22">Ouedraogo JB</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso; Institut des Sciences et Techniques-Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Hamaluba+M%22">Hamaluba M</searchLink>; Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Olotu+A%22">Olotu A</searchLink>; Clinical Trials and Interventions Unit, Ifakara Health Institute, Bagamoyo, Tanzania.<br /><searchLink fieldCode="AU" term="%22Dicko+A%22">Dicko A</searchLink>; The Malaria Research and Training Centre, University of Science, Technology, and Techniques of Bamako, Bamako, Mali.<br /><searchLink fieldCode="AU" term="%22Tinto+H%22">Tinto H</searchLink>; Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso; Institut des Sciences et Techniques-Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Hill+AVS%22">Hill AVS</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Ewer+KJ%22">Ewer KJ</searchLink>; The Jenner Institute Laboratories, University of Oxford, Oxford, UK; GSK Vaccines Institute for Global Health (Global Health Vaccines R&D), GSK, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Ghani+AC%22">Ghani AC</searchLink>; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Winskill+P%22">Winskill P</searchLink>; UK Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2024 May; Vol. 24 (5), pp. 465-475. <i>Date of Electronic Publication: </i>2024 Feb 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38342107 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1473-3099(23)00816-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 465 Titles: – TitleFull: The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schmit N – PersonEntity: Name: NameFull: Topazian HM – PersonEntity: Name: NameFull: Natama HM – PersonEntity: Name: NameFull: Bellamy D – PersonEntity: Name: NameFull: Traoré O – PersonEntity: Name: NameFull: Somé MA – PersonEntity: Name: NameFull: Rouamba T – PersonEntity: Name: NameFull: Tahita MC – PersonEntity: Name: NameFull: Bonko MDA – PersonEntity: Name: NameFull: Sourabié A – PersonEntity: Name: NameFull: Sorgho H – PersonEntity: Name: NameFull: Stockdale L – PersonEntity: Name: NameFull: Provstgaard-Morys S – PersonEntity: Name: NameFull: Aboagye J – PersonEntity: Name: NameFull: Woods D – PersonEntity: Name: NameFull: Rapi K – PersonEntity: Name: NameFull: Datoo MS – PersonEntity: Name: NameFull: Lopez FR – PersonEntity: Name: NameFull: Charles GD – PersonEntity: Name: NameFull: McCain K – PersonEntity: Name: NameFull: Ouedraogo JB – PersonEntity: Name: NameFull: Hamaluba M – PersonEntity: Name: NameFull: Olotu A – PersonEntity: Name: NameFull: Dicko A – PersonEntity: Name: NameFull: Tinto H – PersonEntity: Name: NameFull: Hill AVS – PersonEntity: Name: NameFull: Ewer KJ – PersonEntity: Name: NameFull: Ghani AC – PersonEntity: Name: NameFull: Winskill P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2024 May Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1474-4457 Numbering: – Type: volume Value: 24 – Type: issue Value: 5 Titles: – TitleFull: The Lancet. Infectious diseases Type: main |
| ResultId | 1 |